Service of oncogene sequencing assay

Ended Purchase Order Awarded

Contract number
75N90023P00721
Awardee
Awarding agency
Obligated
$26,926

Award facts

Contract value 100% obligated
$26,926.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20814, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $26,926 purchase order to Q Squared Solutions Expression Analysis LLC for oncogene sequencing assay services. Under this firm fixed price contract, Expression Analysis will provide sequencing of cancer-related genes to support research at the NIH Clinical Center in Bethesda, Maryland through September 30, 2023. No major subcontractors or set aside designations were identified. This purchase order is likely a component of the NIH Clinical Center's broader efforts to advance personalized cancer treatment through genomic analysis.

Quick answers

Who was awarded contract 75N90023P00721?

75N90023P00721 was awarded to Iqvia Laboratories LLC by NIH Clinical Center (National Institutes of Health) on August 17, 2023.

How much is contract 75N90023P00721 worth?

The government has obligated $26,926 on 75N90023P00721.

Was contract 75N90023P00721 competed?

The extent of competition for 75N90023P00721 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login